Ameriprise Financial Inc Amryt Pharma PLC Transaction History

Ameriprise Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.0 - $14.77 $1.35 Million - $2.84 Million	-192,522 Reduced 81.03%	45,086 $657,000
Q4 2021 Feb 14, 2022	SELL	$9.44 - $12.24 $330,400 - $428,400	-35,000 Reduced 12.84%	237,608 $2.57 Million
Q4 2020 Feb 12, 2021	SELL	$12.22 - $14.16 $5.43 Million - $6.29 Million	-444,287 Reduced 61.97%	272,608 $3.86 Million
Q3 2020 Nov 16, 2020	BUY	$10.8 - $13.5 $7.74 Million - $9.68 Million	716,895 New	716,895 $8.82 Million

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.